Apyx Medical (APYX) Equity Ratio (2010 - 2026)
Apyx Medical posted quarterly Equity Ratio of 0.2 for Q1 2026, up 15.08% year-on-year from 0.18 in Q1 2025, and down 6.4% on a QoQ basis from 0.22 in Q4 2025.
Apyx Medical (APYX) has 17 years of Equity Ratio data on file, last reported at 0.2 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 15.08% year-over-year to 0.2; the trailing twelve-month figure through Mar 2026 stood at 0.2 (up 15.08% YoY), and the FY2025 full-year result was 0.22, down 1.6% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.2, down from 0.22 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.79 in Q1 2022 and bottomed at 0.11 in Q3 2025.
- The 5-year median for Equity Ratio is 0.29 (2024), against an average of 0.41.
- The widest annual swing landed in 2024, when Equity Ratio plunged 67.36%; it then gained 15.08% in 2026.
- A 5-year view of Equity Ratio shows it stood at 0.73 in 2022, then sank by 53.46% to 0.34 in 2023, then slumped by 34.93% to 0.22 in 2024, then decreased by 1.6% to 0.22 in 2025, then decreased by 6.4% to 0.2 in 2026.
- The last three Equity Ratio figures came in at 0.2 (Q1 2026), 0.22 (Q4 2025), and 0.11 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn | 0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.20 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.11 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.18 |
| Dec 31, 2024 | 0.22 |
| Sep 30, 2024 | 0.18 |
| Jun 30, 2024 | 0.23 |
| Mar 31, 2024 | 0.29 |
| Dec 31, 2023 | 0.34 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.64 |
| Dec 31, 2022 | 0.73 |
| Sep 30, 2022 | 0.76 |
| Jun 30, 2022 | 0.78 |
| Mar 31, 2022 | 0.79 |
| Dec 31, 2021 | 0.79 |
| Sep 30, 2021 | 0.81 |
| Jun 30, 2021 | 0.83 |
| Mar 31, 2021 | 0.85 |
| Dec 31, 2020 | 0.86 |
| Sep 30, 2020 | 0.85 |
| Jun 30, 2020 | 0.86 |
| Mar 31, 2020 | 0.86 |
| Dec 31, 2019 | 0.84 |
| Sep 30, 2019 | 0.87 |
| Jun 30, 2019 | 0.89 |
| Mar 31, 2019 | 0.90 |
| Dec 31, 2018 | 0.91 |
| Sep 30, 2018 | 0.80 |
| Jun 30, 2018 | 0.70 |
| Mar 31, 2018 | 0.71 |
| Dec 31, 2017 | 0.71 |
| Sep 30, 2017 | 0.73 |
| Jun 30, 2017 | 0.72 |
| Mar 31, 2017 | 0.75 |
| Dec 31, 2016 | 0.75 |
| Sep 30, 2016 | 0.71 |
| Jun 30, 2016 | 0.72 |
| Mar 31, 2016 | 0.73 |
| Dec 31, 2015 | 0.74 |
| Sep 30, 2015 | 0.74 |
| Jun 30, 2015 | 0.76 |
| Mar 31, 2015 | 0.76 |
| Dec 31, 2014 | 0.06 |
| Sep 30, 2014 | 0.22 |
| Dec 31, 2013 | 0.57 |
| Mar 31, 2013 | 0.80 |
| Dec 31, 2012 | 0.81 |
| Sep 30, 2012 | 0.80 |
| Jun 30, 2012 | 0.80 |
| Mar 31, 2012 | 0.80 |
| Dec 31, 2011 | 0.78 |
| Sep 30, 2011 | 0.79 |
| Jun 30, 2011 | 0.79 |
| Dec 31, 2010 | 0.78 |